Important Safety Information for Sermorelin

What is Sermorelin?

Sermorelin is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH), the natural signal your body uses to stimulate growth hormone production from the pituitary gland. Unlike direct growth hormone injection, sermorelin works with your body's own regulatory systems to support growth hormone levels in a more physiologic manner. It is used to address age-related decline in growth hormone and support healthy aging, body composition, and recovery.

General Safety Profile

Sermorelin is generally well-tolerated when used under appropriate medical supervision. Most side effects are mild and temporary, typically resolving without intervention. However, because sermorelin affects hormone production and metabolism, proper monitoring throughout treatment is essential.

Who Should Not Use Sermorelin?

Do not use sermorelin if you:

• Have a known allergy or hypersensitivity to sermorelin or any component of the formulation
• Have active cancer or a history of cancer not in complete remission (growth hormone may promote cell proliferation)
• Are pregnant or planning to become pregnant
• Are breastfeeding
• Have untreated hypothyroidism (can interfere with sermorelin's effectiveness)
• Have growth hormone deficiency caused by intracranial lesions

Warnings and Precautions

1. Cancer Risk ConsiderationsGrowth hormone can potentially stimulate the growth of certain tumors. Sermorelin should not be used by individuals with active malignancies or a history of cancer unless specifically cleared by an oncologist. Regular health monitoring is recommended during therapy.

2. Thyroid FunctionUntreated hypothyroidism (underactive thyroid) can significantly reduce sermorelin's effectiveness. Thyroid function should be evaluated before starting therapy and optimized if necessary. Patients taking thyroid medications should inform their provider, as adjustments may be needed.

3. Metabolic EffectsBecause sermorelin affects growth hormone levels, it can influence blood sugar regulation and insulin sensitivity. Patients with diabetes or prediabetes should be monitored more closely during treatment.

4. Hormonal BalanceSermorelin therapy affects the broader hormonal system. Your provider may recommend monitoring of related hormones including insulin-like growth factor-1 (IGF-1), cortisol, and thyroid markers throughout treatment.

5. Allergic ReactionsWhile uncommon, allergic reactions to sermorelin can occur. Symptoms may include rash, hives, itching, swelling, or difficulty breathing. Seek immediate medical attention for any signs of severe allergic reaction.

6. Injection Site ReactionsAs with any injectable medication, local reactions at the injection site are possible and represent the most common side effect.

Common Side Effects

The most frequently reported side effects include:

Injection Site Reactions:

• Pain, redness, or swelling at the injection site
• Itching or sensitivity
• Mild bruising

Systemic Effects (Less Common):

• Facial flushing or warmth
• Headache
• Dizziness
• Mild nausea
• Fatigue or sleepiness
• Temporary taste changes
• Difficulty sitting still or restlessness

Most side effects are mild, transient, and resolve on their own without medical intervention.

Rare but Serious Side Effects

Seek immediate medical attention if you experience:

• Severe allergic reaction (difficulty breathing, facial/throat swelling, severe rash)
• Significant swelling (edema) in hands, feet, or face
• Difficulty swallowing
• Chest pain or irregular heartbeat
• Persistent or severe headache
• Vision changes

Pregnancy and Breastfeeding

Pregnancy: Sermorelin is not recommended during pregnancy. Safety in pregnant women has not been established. Use effective contraception during treatment unless otherwise directed by your provider.

Breastfeeding: It is unknown whether sermorelin passes into breast milk. Due to potential risks to nursing infants, breastfeeding is not recommended during sermorelin therapy.

Drug Interactions

Sermorelin may interact with certain medications:

• Glucocorticoids (e.g., prednisone, cortisone): May reduce the effectiveness of sermorelin by suppressing growth hormone secretion
• Thyroid medications: May require dosage adjustments and additional monitoring
• Insulin and diabetes medications: Blood sugar effects should be monitored
• Other hormone therapies: Discuss all hormone treatments with your provider

Always inform your healthcare provider about all medications, supplements, and herbal products you use.

Administration Guidelines

• Sermorelin is typically administered as a daily subcutaneous injection
• Evening administration (at bedtime) is often recommended to align with natural growth hormone release during sleep
• Rotate injection sites (abdomen, thigh, upper arm) to prevent tissue irritation
• Use sterile injection technique and dispose of needles properly
• Follow your provider's dosing instructions exactly—do not adjust doses without medical guidance

Storage Instructions

Injectable Sermorelin:

• Store refrigerated at 36-46°F (2-8°C)
• Do not freeze
• Protect from light
• Use within the timeframe specified by your pharmacy after reconstitution
• Do not use if solution is cloudy or contains particles

Keep out of reach of children and pets.

Monitoring Recommendations

Your healthcare provider may recommend:

• Baseline and periodic blood tests to assess growth hormone levels and IGF-1
• Thyroid function testing
• Metabolic panel to monitor blood sugar and kidney function
• Regular follow-up appointments to assess response and adjust therapy

When to Contact Your Healthcare Provider

Reach out to your provider if you experience:

• Side effects that persist or worsen
• Signs of infection at injection sites
• Unusual fatigue, weakness, or mood changes
• Any symptoms that concern you

Reporting Side Effects

You are encouraged to report side effects to the FDA at www.fda.gov/medwatch or by calling 1-800-FDA-1088.

Disclaimer

This information is intended for educational purposes and does not replace professional medical advice. Compounded sermorelin has not been reviewed by the FDA for safety, effectiveness, or quality. Consult your healthcare provider with any questions regarding sermorelin therapy.